Create a 30-40 page journal club powerpoint presentation for an audience of pharmacy residency preceptors

Created using ChatSlide

This presentation explores the impact of Nivolumab plus AVD on frontline treatment for advanced classical Hodgkin lymphoma (cHL). It covers the design and results of the Phase 3 S1826 trial conducted across 256 sites in North America, focusing on patient eligibility and outcomes. Additionally, it emphasizes the importance of translating clinical evidence into pharmacy practice, particularly for newly diagnosed patients, and addresses considerations for adolescent patients regarding dosing and...